BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 16, 2007
View Archived Issues
Long-acting antithrombotic oligosaccharides profiled at sanofi-aventis
Read More
New therapeutic options for cancer imparted in recent patents
Read More
Clinical protocol submitted in India for phase II trial of bavituximab in NSCLC
Read More
Recent Bristol-Myers Squibb patent discloses novel therapeutics for thrombotic disorders
Read More
Topical ketoprofen patch fails to meet primary endpoint in phase III trials
Read More
R-763 begins new phase I study for advanced malignancies
Read More
TRC-093 begins phase I study in cancer
Read More
In vitro efficacy of CD-160130, a PDE4 inhibitor, in chronic lymphocytic leukemia
Read More
Preclinical and clinical data on Novo Nordisk's recombinant FVIIa analogue NN-1731
Read More
New uses for the PDE5 inhibitor udenafil
Read More
FM-19 shows activity in murine models of thrombosis
Read More
Affiris mimotope-based Alzheimer's disease vaccine enters the clinic
Read More
Topline findings from North American Zuidex study
Read More
Novel diagnostic agents disclosed in recent Bracco patent
Read More
Amgen and Daiichi collaborate on development of denosumab in Japan
Read More
Sciele Pharma and Addrenex agree to market Clonicel in North America
Read More
LAB reports positive interim results from phase II study of LAB GHRH
Read More
LifeCycle Pharma to begin phase II trial of LCP-AtorFen for high cholesterol
Read More
TZP-101 receives fast track designation for treatment of gastroparesis
Read More
Update on GTx's two pivotal phase III trials of Acapodene
Read More
Avalon begins enrollment for phase II trial of AVN-944
Read More
Positive phase II results for dose-finding study of oral Rambazole
Read More
Lubiprostone filed for IBS-C
Read More
